Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biodetection & Biosensors 2016

Deborah Hung's Biography

Deborah Hung, Associate Professor, Broad Institute of MIT and Harvard

Dr. Deborah Hung is an associate professor in the Department of Molecular Biology at Massachusetts General Hospital and in the Department of Microbiology and Immunobiology at Harvard Medical School, and the director of the Infectious Disease Program at the Broad Institute of MIT and Harvard. She also holds positions as an infectious disease physician at Brigham and Women’s Hospital and Massachusetts General Hospital and is an attending critical care physician in the Pulmonary and Critical Care Division, attending in the Medical Intensive Care Unit at Brigham and Women’s Hospital. She has been awarded the American Society for Microbiology Merck Irving S. Sigal Memorial Award, a Pew Scholars Award in the Biomedical Sciences, Kavli fellowship from the National Academ of Sciences, and a Doris Duke Foundation Clinical Scientist Development Award. She has served on the Scientific Advisory boards of the New England Center for Excellence in Biodefense, of the Pew Foundation Initiative in Antibiotic Resistance, and contributed to the President’s Council of Advisors on Science and Technology report on Combatting Antibiotic Resistance. She has chaired the Boston Area Antibiotic Resistance Network Symposium and a Keystone meeting on the Challenges of Antibiotic Resistance.
She received her A.B. from Harvard University, Ph.D. from Harvard University, and M.D. from Harvard Medical School. She completed a residency in internal medicine and fellowships in infectious disease and critical care medicine at Brigham and Women’s Hospital and Massachusetts General Hospital.

Deborah Hung Image

RNA Based Diagnosis of Antibiotic Resistance

Wednesday, 19 October 2016 at 11:45

Add to Calendar ▼2016-10-19 11:45:002016-10-19 12:45:00Europe/LondonRNA Based Diagnosis of Antibiotic ResistanceBiodetection and Biosensors 2016 in Cambridge, UKCambridge,

Rapid diagnostics to rapidly identify a pathogen and provide drug susceptibility is critical for preparedness against bioterrorism. In particular, the need to generate real-time drug susceptibility patterns is mounting in the face of increasing natural antibiotic resistance and the possibility of engineered multi-drug resistant bioterrorist pathogens. The detection of RNA expression signatures can serve as such a diagnostic platform.

Add to Calendar ▼2016-10-18 00:00:002016-10-19 00:00:00Europe/LondonBiodetection and Biosensors 2016Biodetection and Biosensors 2016 in Cambridge, UKCambridge,